Safety

News

GSK's halts RSV vaccine trials in pregnant women after pause

It looks like GlaxoSmithKline's concerns about its respiratory syncytial virus (RSV) vaccine in pregnant women aren't going to be resolved quickly.

News

Safety probe prompts GSK to halt RSV jab study in pregnant w...

GlaxoSmithKline has a lot riding on its respiratory syncytial virus (RSV) vaccine, which it thinks could be a

News

Merck will assess Quris' AI 'patient-on-a-chip' drug safety ...

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic can

News

Astellas says Pompe gene therapy clears safety hurdle

With the safety of gene therapies thrown into the spotlight by a series of FDA clinical holds, Astellas has said that an interim readout in a phase 1/2 trial of its Pompe disease candidate

News

FDA slaps hold on trials of Gilead's CD47 drug magrolimab

The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences' magrolimab, the centre piece of its $4.9 billion

News

PureTech challenges Roche's Esbriet in head-to-head IPF tria...

Roche's idiopathic pulmonary fibrosis (IPF) therapy Esbriet is already being squeezed by its main rival in the market, and could come under renewed pressure if another competitor from PureT